CNSY Cerenome, Inc.
Company Analysis
Latest News
🟢 Cerenome is trading 5% up on October 6 with no clear company-specific catalyst identified
Cerenome is trading at $1.64, up 5.10%, with no clear company-specific catalyst identified for the October 6 move. - The latest listed company news is an...
🟢 Cerenome is trading 12.2% up in pre-market
Cerenome is trading 12.16% up in pre-market at $1.75, compared with its October 5 close of $1.56; no clear company-specific catalyst for the October 6 move was...
🟢 Cerenome is trading 5.77% up in pre-market with no clear company-specific catalyst identified
Cerenome is trading 5.77% up at $1.65 in pre-market on October 6, 2026, compared with the October 5 close of $1.56. No clear company-specific catalyst for the...
🔴 Cerenome is trading 5.6% down; no October 5 catalyst identified
Cerenome is trading at $1.51, down 5.63%, with the reason for the decline unclear. - No specific October 5 catalyst was identified in available company news....
🔴 Cerenome is trading 9.8% down in after-hours trading; no confirmed catalyst identified
Cerenome is trading at $1.44, down 9.8% after hours, with no clear company-specific catalyst identified. - It closed at $1.60 on October 2, 2026; supplied...
🔴 Cerenome is trading 10.1% down with no clear catalyst identified
Cerenome is trading 10.1% lower at $1.60, with no clear October 2 company-specific catalyst identified. - Lake Street lowered its price target from $50 to $31...
🔴 Cerenome is trading 7% down with no clear October 2 company-specific catalyst identified
Cerenome is trading at $1.66, down 6.65%, with no clear October 2 company-specific catalyst identified. - On October 1, Lake Street lowered its price target...
🔴 Cerenome is trading 5% down in after-hours trading with no clear catalyst identified
Cerenome is trading 5.06% down at $1.69 after the October 1 regular session closed at $1.78; no clear company-specific catalyst for the after-hours decline was...
🔴 Cerenome is trading 11% down with no same-day company-specific negative catalyst identified
Cerenome is trading at $1.67, down 10.70%, with no same-day company-specific negative catalyst identified. - The September 30 update reported 222 CNSide tests...
🔴 Cerenome is trading 7% down with no same-day company-specific negative catalyst identified
Cerenome is trading 6.95% down at $1.74 on October 1; healthcare-sector weakness may add pressure, but no same-day company-specific negative catalyst was...
🟢 Cerenome is trading 18.18% up today after CNSide reported $1.55 million in Q3 billings
Cerenome is trading 18.18% up at $2.21 on October 1, 2026, following its September 30 business update on Q3 gross billings. - CNSide billed 222 tests for...
🟢 Cerenome is trading 7% up today after reporting $1.55 million in Q3 gross billings
Cerenome is trading at $2.00, up 6.95%, following its September 30 business update, which reported unaudited Q3 gross billings. - The update reported $1.55...
🟢 Cerenome shares surge on strong Q3 billings and positive CMS pricing decision
Cerenome (CNSY) is trading at $2.00, up 7.53%, following a positive Q3 business update. The company reported $1.55 million in unaudited Q3 gross billings...
🟢 Cerenome is trading 6.5% up in pre-market with no identified catalyst
Cerenome is trading 6.5% up at $1.98 in pre-market on September 30, 2026; no new company announcement explaining the move was identified. - A CNSide business...
🔴 Cerenome is trading 5% down
Cerenome is trading at $1.91, down -5.45%, with no company-specific announcement identified to explain the September 29 decline. - Cerenome had announced a...
Cerenome's Business Update Tease Sparks a 10.7% Rally, but Can a $2 Stock Turn Commercial Promises Into Real Revenue?
Cerenome Jumps 10.7% on a Promise to Talk — Can a Micro-Cap Diagnostics Play Convert Insurance Deals Into Actual Revenue? Shares shifted as Cerenome (CNSY)...
🟢 Cerenome is trading 10.70% up today after announcing September 30 CNSide commercial update call
Cerenome is trading 10.70% up at $2.07 after announcing a September 30, 2026, business update call focused on CNSide commercial progress. - Management plans to...
🟢 Cerenome is trading 6.4% up today after announcing September 30 CNSide commercial update call
Cerenome is trading 6.4% higher at $1.99 after announcing a September 30 business update call focused on CNSide commercial progress. - Topics include...
CNSide Wins Blue Cross Michigan Coverage for Brain Tumor Test — But Can a Single Payer Deal Move the Needle for a $2 Stock?
Shares of Cerenome (CNSY) jumped 10.5% to $2.10 on Monday after its diagnostics unit, CNSide Diagnostics, announced that Blue Cross Blue Shield of Michigan...
🟢 Cerenome is trading 10.53% up today after Blue Cross Blue Shield of Michigan agreement
Cerenome is trading 10.53% up at $2.10 after CNSide Diagnostics announced a Blue Cross Blue Shield of Michigan in-network provider agreement effective...